mammal (species unspecified) |
LD50 |
unreported |
31mg/kg (31mg/kg) |
BEHAVIORAL: EUPHORIA
BEHAVIORAL: ANTIPSYCHOTIC |
Pharmaceutical Chemistry Journal Vol. 8, Pg. 409, 1974. |
man |
TDLo |
oral |
176mg/kg/7W-I (176mg/kg) |
GASTROINTESTINAL: NAUSEA OR VOMITING
LIVER: LIVER FUNCTION TESTS IMPAIRED |
Australian and New Zealand Journal of Medicine. Vol. 20, Pg. 193, 1990. |
mouse |
LD50 |
intramuscular |
29mg/kg (29mg/kg) |
|
Drugs of the Future. Vol. 15, Pg. 126, 1990. |
mouse |
LD50 |
intraperitoneal |
20mg/kg (20mg/kg) |
|
Indian Journal of Pharmacology. Vol. 19, Pg. 44, 1987. |
mouse |
LD50 |
oral |
39800ug/kg (39.8mg/kg) |
|
Journal of Medicinal Chemistry. Vol. 31, Pg. 1278, 1988. |
mouse |
LD50 |
subcutaneous |
25mg/kg (25mg/kg) |
|
British Journal of Experimental Pathology. Vol. 28, Pg. 1, 1947. |
rat |
LD50 |
intramuscular |
34mg/kg (34mg/kg) |
|
Drugs of the Future. Vol. 15, Pg. 126, 1990. |
rat |
LD50 |
intraperitoneal |
30mg/kg (30mg/kg) |
|
Iugoslavica Physiologica et Pharmacologica Acta. Vol. 3, Pg. 43, 1967. |
rat |
LD50 |
oral |
70mg/kg (70mg/kg) |
|
Journal of Medicinal Chemistry. Vol. 38, Pg. 2802, 1995. |
rat |
LDLo |
intravenous |
20mg/kg (20mg/kg) |
|
United States Patent Document. Vol. #5409948, |
women |
TDLo |
oral |
84mg/kg/6W-I (84mg/kg) |
LIVER: "HEPATITIS (HEPATOCELLULAR NECROSIS), ZONAL"
LIVER: LIVER FUNCTION TESTS IMPAIRED |
Australian and New Zealand Journal of Medicine. Vol. 20, Pg. 193, 1990. |
women |
TDLo |
oral |
294mg/kg/14W- (294mg/kg) |
LIVER: FATTY LIVER DEGERATION
LIVER: LIVER FUNCTION TESTS IMPAIRED
BLOOD: CHANGES IN CELL COUNT (UNSPECIFIED) |
Lancet. Vol. 1, Pg. 887, 1988. |